A detailed history of Apollon Wealth Management, LLC transactions in Centogene N.V. stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 22,184 shares of CNTG stock, worth $8,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,184
Previous 12,595 76.13%
Holding current value
$8,429
Previous $15,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$0.65 - $1.25 $6,232 - $11,986
9,589 Added 76.13%
22,184 $15,000
Q4 2023

Feb 06, 2024

BUY
$1.02 - $1.47 $12,846 - $18,514
12,595 New
12,595 $15,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $10.3M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.